Novartis will continue to do bolt-on deals and its capital allocation priorities remain unchanged, CEO Vasant Narasimhan said ...

Report projects market growth but investors remain in cautious recovery mode LONDON – [7 January 2026] – Evaluate, the ...

Novartis recently announced it has reached an agreement with the U.S. government that aims to lower the price of innovative ...

The rise in Medicare premiums and deductibles will be offset by a cap on drug prices. The Inflation Reduction Act of 2022, ...

Getting a strong early start, consumers embraced convenience and connection through the season, blending online and in-store purchases and dining out as a festive tradition. The four students told us ...

This report from Towards Healthcare, a sister firm of Precedence Research, provides a comprehensive analysis of the upcoming ...